A girl child has had recurrent yeast infections and respiratory virus infections since she was 3 months old. Which of the following vaccine is contraindicated considering her immune status?

Correct Answer: A. Measles/MMR

The clinical presentation of recurrent yeast infections (Candida) and respiratory virus infections starting at 3 months of age is pathognomonic for T-cell immunodeficiency, most commonly DiGeorge syndrome (22q11 deletion) or severe combined immunodeficiency (SCID) in the Indian pediatric population. The key discriminator is that live attenuated vaccines are absolutely contraindicated in T-cell immunodeficiency because the vaccine virus itself can cause disseminated disease in an immunocompromised host. Measles/MMR is a live attenuated vaccine and poses a direct risk of vaccine-strain measles dissemination, encephalitis, and death in a child with defective cell-mediated immunity. According to IAP guidelines and Harrison's Principles, live vaccines (MMR, varicella, rotavirus, oral polio) must be withheld until immune reconstitution is documented. In contrast, inactivated vaccines (IPV, TT, DPT) do not replicate and are safe, though their efficacy may be reduced due to poor antibody response. The clinical pearl is that any child presenting with opportunistic infections (Candida, PCP, CMV) before 6 months should trigger immediate immunological workup and vaccine contraindication assessment before routine immunization.

Why the other options are wrong

B. Killed IPV — IPV is an inactivated (killed) vaccine that does not replicate and cannot cause disseminated disease in immunocompromised children. It is safe to administer and is actually recommended in T-cell deficiency. The trap is confusing IPV (killed) with OPV (live attenuated), which would be contraindicated. IAP guidelines explicitly permit inactivated polio vaccine in immunodeficiency. C. TT/Td — Tetanus toxoid is an inactivated toxin-based vaccine with no replication capability, making it safe in immunodeficiency. It does not confer protective immunity as effectively in T-cell deficiency, but it poses no risk of vaccine-strain disease. NBE may trap students into thinking all vaccines are contraindicated, when only live vaccines are truly dangerous. D. DPT — DPT contains inactivated diphtheria toxoid, inactivated pertussis antigen, and inactivated tetanus toxoid—all killed components with no replication. While antibody response may be suboptimal in T-cell deficiency, the vaccine is safe and does not cause disseminated disease. The question specifically asks for contraindication, not reduced efficacy.

High-Yield Facts

Mnemonics

LIVE vaccines = DANGER in T-cell deficiency LIVE: Measles, Varicella, OPV, Rotavirus, Yellow fever. KILLED SAFE: IPV, DPT, TT, Hepatitis B, Inactivated flu. Use when assessing vaccine safety in any immunocompromised child. Candida + Virus = Cell-mediated immunity problem Candida (fungal) + viral infections = T-cell defect (not B-cell). B-cell deficiency → bacterial infections (Strep, Staph). Quick discriminator for vaccine contraindication type.

NBE Trap

NBE pairs "recurrent infections" with "vaccine contraindication" to trap students into thinking all vaccines are unsafe. The discriminator is live vs. killed—only live vaccines replicate and disseminate in immunodeficiency. Students may incorrectly eliminate DPT or TT thinking they are also contraindicated.

Clinical Pearl

In Indian pediatric practice, any child presenting with oral candidiasis and recurrent respiratory infections before 6 months should be flagged for immunological evaluation before routine immunization. Administering MMR to such a child can trigger vaccine-strain measles dissemination within 2–4 weeks, presenting as severe pneumonitis or encephalitis—a preventable tragedy if immunodeficiency is recognized early.

_Reference: IAP Immunization Guidelines 2023; Harrison Ch. 297 (Immunodeficiency); Park's Textbook of Preventive and Social Medicine Ch. 7 (Vaccines)_